Clover Health Investments, Corp.

We're still checking in participants for today's conference call. Thank you for your patience and please continue to stand by. Thank you. Bye. Ball locations on hold. We're still checking in. participants for today's conference. Thank you for your patience and please stand by. We'll begin in approximately one minute. Thank you. Please stand by. Your program is about to begin. If you need assistance on today's call, please press star zero. Ladies and gentlemen, good day and welcome to the Clover Health first quarter 2022 earnings conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the prepared remarks. At that time, if you wish to ask a question, please press star one on your telephone keypad. As a reminder, today's call is being recorded. I would now like to turn the call over to Derek Newman, Head of Investor Relations and Corporate Strategy for Clover Health.

Please go ahead. Good afternoon, everyone.

Joining me on the call today is our CEO, Vivek Garapalli, our President, Andrew Twyfe, and our Interim CFO, Mark Herbers. We will discuss first-quarter results and answer your questions. This call is being recorded. Before we get started, I would like to remind you that our first quarter's earnings materials, including the release, are available on our website at cloverhealth.com. I'd also like to caution you that we may make forward-looking statements during today's call that are subject to risk and uncertainties, including expectations about future performance. Factors that may cause actual results to differ materially from expectations are detailed in our SEC filings, including in the risk factors section of our most recent annual report on Form 10-K, and in our other SEC filings. Information about non-GAAP financial measures referenced including the reconciliation of those measures to GAAP measures can be found in earnings materials available on our website. Lastly, I want to note we updated the names of our Medicare Advantage and direct contracting segments to our insurance and non-insurance segments, respectively. We believe that this better reflects each segment's current role and contribution to our business. There has been no change to the existing composition of these segments, and previously reported financial results were not impacted by these changes. Finally, direct contracting will be known as ACO REACH starting next year and will fall into our non-insurance segment.